TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: modified NFCS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in heart rate and oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Increased resilience
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: emotional empathy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dizziness Handicap Inventory (DHI) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dizziness visual analog scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Limit of stability areas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anaesthetic drug requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Postoperative cognitive decline (POCD)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Complete mucosal healing by week 10
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Complete mucosal healing at week 54
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Improvement in CDEIS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Need for repeated interventions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Area under the triacylglycerol-time curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean vertical implant level discrepancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: buccolingual implant position discrepancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: mesio‐distal implant position discrepancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Intraocular pressure (IOP) measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma uric acid levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Response to treatment in bipolar TRD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in pain-free walking distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of critical cardiovascular events
Endpoint domain: Adverse events/effects
Primary endpoint: Survival to 28 days after onset of sepsis
Endpoint domain: Mortality/survival
Primary endpoint: Probability of treatment success following ankle joint mobilizations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of treatment success following plantar massage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of treatment success following calf stretching
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean visual analogue scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Treatment efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak SAR levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delay in care-home admissions
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Histomorphometric parameters of bone volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in performance and satisfaction ratings on the COPM
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in severity of motor overflow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Therapeutic effect rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Per-patient adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: clinical competence score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: access loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Frequency of post-ERCP pancreatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Post-procedure amylase levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Endometrial histological differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Baseline permeability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 28-day mortality for HEV-related liver failure
Endpoint domain: Mortality/survival
Primary endpoint: 90-day mortality for HEV-related liver failure
Endpoint domain: Mortality/survival
Primary endpoint: Dietary Knowledge, Attitude, and Behavior score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in glucose tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean dmft difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sildenafil clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: steady-state maximum sildenafil concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of Internet interventions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean exercise-induced desaturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Parental involvement in infant pain management
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: SF-36 bodily pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total back pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Salivary fistulas
Endpoint domain: Adverse events/effects
Primary endpoint: Low cardiac output syndrome
Endpoint domain: Adverse events/effects
Primary endpoint: Myocardial injury
Endpoint domain: Adverse events/effects
Primary endpoint: serum levels of lipid peroxides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Duration of the third stage of labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Hematocrit values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Center of Rotation (COR) shift
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sagittal rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Translation at the level above fusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity for detecting vocal fold paralysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BBS scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UPDRS II/III improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reverse remodelling response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Efficacy of ibuprofen liquigel compared to placebo
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Onset to confirmed first perceptible relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Onset to meaningful relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to recovery of T1 to 25% of control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to recovery of T1 to 90% of control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma cholinesterase activity (PCHE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Target Lesion Revascularization (TLR) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Adverse events (grade 3, 4, and 5)
Endpoint domain: Adverse events/effects
Primary endpoint: Sustained Virologic Response (SVR) 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality due to liver complications
Endpoint domain: Mortality/survival
Primary endpoint: Adverse events during treatment
Endpoint domain: Adverse events/effects
Primary endpoint: risks of death or major disability
Endpoint domain: Mortality/survival
Primary endpoint: AUC(t) ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incontinence Severity Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pelvic Floor Distress Inventory‐Short Form 20
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary Distress Inventory‐Short Form
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in verbal learning and memory scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: BASFI-AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EQ-5D(utility)-AUC
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incremental cost-effectiveness ratio per unit effect gained in functional ability
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Correlation of TM temperatures with hospital temperatures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean high-density lipoprotein cholesterol (HDL-C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Cobb angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Kyphometer-measured kyphosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: SRS-30 self-esteem
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: American Society of Anesthesiologists score of 3 or greater
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum creatinine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Left amygdala volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: progression-free survival benefit
Endpoint domain: Mortality/survival
Primary endpoint: Sensitivity and accuracy of diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraclass correlation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis coincidence rate with needle biopsy results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of LAIV against moderate-to-severe LCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total effective rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: number of emesis episodes
Endpoint domain: Adverse events/effects
Primary endpoint: doses of analgesia given
Endpoint domain: Adverse events/effects
Primary endpoint: Lee CHF score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Classification of functional capacity of the NYHA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ejection Fraction (EF) improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: time taken to complete the sit-to-stand test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time taken to walk 10 m
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anterior capsule contraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of postoperative junctional ectopic tachycardia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in systolic blood pressure (SBP) over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in diastolic blood pressure (DBP) over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of postprandial hypotension (PPH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: hot flush interference with daily life activities
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Response rate (complete and partial)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of participants with correct technique
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: service satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: recovery-oriented outcomes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rate of dropout due to good prognosis
Endpoint domain: Adverse events/effects
Primary endpoint: Number of symptomatic attacks per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of days without heartburn
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of non-fatal myocardial infarction (MI)
Endpoint domain: Mortality/survival
Primary endpoint: Urinary levels of NAG and RBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Diagnosis of clinically significant lesions (Gleason ≥ 7)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: VAS score for pain with overhead activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total milligrams of bupivacaine used
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain with pushing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median satisfaction scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean total area under the plasma concentration‐time curve (AUC(0‐infinity)) of pioglitazone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elimination half‐life (t(1/2)) of pioglitazone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone level in the grafted area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impaction of cleft-side canines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gingival retraction
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of PDPB
Endpoint domain: Adverse events/effects
Primary endpoint: recurrence of atrial tachyarrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in lung function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Vascular endothelial function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: muscle coactivation patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage rbc‐AChE inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical and bacteriological efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ED symptomatology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: general functioning
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Acceptability of the trial
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean logMAR BCVA improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean flare measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean bodyweight change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total serum cholesterol change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Grade 4 nephrotoxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Central venous line infections
Endpoint domain: Adverse events/effects
Primary endpoint: percentage of days alive and out of the hospital
Endpoint domain: Mortality/survival
Primary endpoint: quality of life (Medical Outcome Survey Short Form‐36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: FIM total change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IIEF‐5 score improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: SF‐36 score improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: number of lane deviations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of randomized controlled trials
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of systematic reviews
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: clinical success (cure or improvement)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: microbiologic eradication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Erections of >60% rigidity at the penile base
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in erections reported by subjects
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Willingness to continue treatment
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: MGD (Meibomian Gland Dysfunction)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in the number of drinks/drinking day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of implantation failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Live birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Composite event rates of death or clinically significant decline in HRQOL
Endpoint domain: Adverse events/effects
Primary endpoint: DeltaSSS improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall abdominal strength development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction of body fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oculomotor skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: periodontal clinical parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of uncomfortable abdominal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biofilm thickness (BT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean vitality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VSC formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AIDS-related deaths
Endpoint domain: Mortality/survival
Primary endpoint: diarrhea-related deaths
Endpoint domain: Mortality/survival
Primary endpoint: Magnitude of decrease in RSS at day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Lower-extremity revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Trichomoniasis infection status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Surgical Site Infections (SSI) rate
Endpoint domain: Adverse events/effects
Primary endpoint: Average time to expulsion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Improvement in physical health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in social relationship
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Vasopressor requirements
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Decline in viral RNA levels in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decline in proviral DNA levels in cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of symptoms at hospital admission or discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion rate of lessons
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention